Current stock page

Financial Data

HIMS Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - Care FacilitiesScore data as of Sep 4, 2026

HIMS

Financial Data
Hims & Hers Health, Inc.
Healthcare· Medical - Care Facilities
AIQ Score
BearishAIQ Edge 2/10
Low Priority
Relative Laggard
Score data as of Sep 4, 2026
Last price
$27.71
-$0.11 (-0.40%)
Latest market quote
Momentum39
Value58
Quality29
Risk Resilience19
Sentiment
View financial data

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Sep 6, 2026.

Income statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Revenue$753.21M$608.1M$617.82M$598.98M$544.83M$586.01M$481.14M$401.56M
Gross Profit$480.8M$300.28M$444.44M$442.06M$416.2M$430.69M$369.54M$317.89M
Operating Income
Net Income-$86.29M-$92.12M$20.6M$15.77M$42.51M$49.49M$26.03M$75.59M
EPS-$0.37-$0.4$0.09$0.07$0.19$0.22$0.12$0.35
Cash flow statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Operating Cash Flow-$35.94M$89.36M$64.7M$148.72M-$19.12M$109.09M$86.39M$85.27M
Capital Expenditure-$19.45M-$36.32M-$63.88M-$57.3M-$50.32M-$59.04M-$26.89M-$5.88M
Free Cash Flow-$55.39M$53.03M$821K$91.42M-$69.43M$50.05M$59.5M$79.39M
Net Cash Provided By Operating Activities-$35.94M$89.36M$64.7M$148.72M-$19.12M$109.09M$86.39M$85.27M
Balance sheet
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Assets$3.63B$2.27B$2.15B$2.23B$1.88B$891.71M$707.54M$602.26M
Total Debt$1.55B$1.13B$1.12B$1.12B$1.04B$63.38M$11.35M$11.36M
Cash And Cash Equivalents
Total Liabilities$3.3B$1.82B$1.61B$1.65B$1.31B$342.45M$230.82M$162.21M
Total Stockholders Equity$324.07M$446.17M$540.93M$580.98M$562.7M$549.26M$476.72M$440.05M
Key financial metrics
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio-23.43-12.9890.19203.4765.7933.1450.8713.2
P/B ratio24.7910.6313.6322.119.8811.9411.119.07
P/S ratio10.677.811.9321.4320.5311.1911.019.94
Debt To Equity4.772.542.071.921.860.120.020.03
Free Cash Flow Yield
Financial ratios
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio
P/B ratio24.7910.6313.6322.119.8811.9411.119.07
P/S ratio10.677.811.9321.4320.5311.1911.019.94
Return On Equity-26.63%-20.65%3.81%2.72%7.55%9.01%5.46%17.18%
Debt To Equity

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
Pe
-46.62
multipleSep 4, 2026
Pb
20.34
multipleSep 4, 2026
Revenue Growth Yoy
23.86
percentSep 4, 2026
EPS Growth Yoy
7.5
percentSep 4, 2026
Gross Margin
64.68
percentSep 4, 2026
Operating Margin
-3.59
percentSep 4, 2026
ROE
-30.03
percentSep 4, 2026
ROIC
-3.73
percentSep 4, 2026
Debt To Equity
4.77
ratioSep 4, 2026
FCF Yield
1.42
percentSep 4, 2026
Technical indicators
Close
27.71
priceSep 4, 2026
Volume
7,181,866
volumeSep 4, 2026
Rsi14
47.82
indexSep 4, 2026
MACD
-0.67
indexSep 4, 2026
MACD Signal
-0.4
indexSep 4, 2026
MACD Histogram
-0.27
indexSep 4, 2026
Adx14
11.3
indexSep 4, 2026
Sma50
31.61
priceSep 4, 2026
Sma200
28.38
priceSep 4, 2026
Atr14
2.04
priceSep 4, 2026
Historical Volatility
0.84
percentSep 4, 2026
Volume Ma20
12,689,302.95
volumeSep 4, 2026
Risk measures
Resilience Score
19
score_0_100Sep 4, 2026
Beta
2.42
ratioSep 4, 2026
Volatility Annual
93.28
percentSep 4, 2026
Max Drawdown
-76.86
percentSep 4, 2026
Sharpe Ratio
-0.19
ratioSep 4, 2026
Var95
-7.94
percentSep 4, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

HIMS Financial Data FAQ

What is Hims & Hers Health, Inc.'s revenue?

Hims & Hers Health, Inc.'s revenue is one of the core financial data points for HIMS. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Hims & Hers Health, Inc.'s revenue growing?

Revenue growth shows whether Hims & Hers Health, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is HIMS's EPS?

HIMS's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Hims & Hers Health, Inc.'s net income?

Hims & Hers Health, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Hims & Hers Health, Inc. generate?

Free cash flow shows how much cash Hims & Hers Health, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Hims & Hers Health, Inc. have?

Cash and debt help frame HIMS's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.